ATXN7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.106000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.280450E-01
Normal-vs-Stage2
3.262200E-01
Normal-vs-Stage3
6.402300E-02
Normal-vs-Stage4
4.059200E-01
Stage1-vs-Stage2
9.701000E-01
Stage1-vs-Stage3
6.913600E-02
Stage1-vs-Stage4
2.715200E-01
Stage2-vs-Stage3
5.983600E-02
Stage2-vs-Stage4
2.807600E-01
Stage3-vs-Stage4
1.845710E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.132200E-01
Normal-vs-AfricanAmerican
2.415600E-01
Normal-vs-Asian
2.323800E-01
Caucasian-vs-AfricanAmerican
5.787800E-01
Caucasian-vs-Asian
1.317050E-01
AfricanAmerican-vs-Asian
1.858020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.105800E-01
Normal-vs-Female
3.125600E-01
Male-vs-Female
9.606600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.425600E-01
Normal-vs-Age(41-60Yrs)
4.476400E-02
Normal-vs-Age(61-80Yrs)
2.965000E-01
Normal-vs-Age(81-100Yrs)
2.299000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.411200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.994400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.052400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.019700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.995600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.819400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.929000E-01
Normal-vs-Daily Drinker
2.489200E-01
Normal-vs-Weekly Drinker
6.383900E-02
Normal-vs-Occasional Drinker
2.818400E-01
Normal-vs-Social Drinker
7.818500E-02
Non Drinker-vs-Daily Drinker
3.507000E-01
Non Drinker-vs-Weekly Drinker
8.340600E-01
Non Drinker-vs-Occasional Drinker
8.165000E-01
Non Drinker-vs-Social Drinker
5.107000E-01
Daily Drinker-vs-Weekly Drinker
6.398200E-01
Daily Drinker-vs-Occasional Drinker
5.305200E-01
Daily Drinker-vs-Social Drinker
1.787400E-01
Weekly Drinker-vs-Occasional Drinker
9.829400E-01
Weekly Drinker-vs-Social Drinker
5.317200E-01
Occasional Drinker-vs-Social Drinker
4.383000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.182420E-01
Normal-vs-Grade 2
1.319620E-02
Normal-vs-Grade 3
1.473830E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.770000E-01
Grade 1-vs-Grade 3
5.490000E-01
Grade 1-vs-Grade 4
1.182420E-01
Grade 2-vs-Grade 3
7.234200E-01
Grade 2-vs-Grade 4
1.319620E-02
Grade 3-vs-Grade 4
1.473830E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.763780E-02
Normal-vs-NonDiabetic
2.788600E-01
Diabetic-vs-NonDiabetic
6.345800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.482400E-01
Normal-vs-NoPancreatitis
2.913000E-01
Pancreatitis-vs-NoPancreatitis
3.835000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.384400E-02
Normal-vs-N1
3.229400E-01
N0-vs-N1
4.465600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.104600E-01
Normal-vs-TP53-NonMutant
9.486400E-02
TP53-Mutant-vs-TP53-NonMutant
1.810020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
